We are live on ! Find out more
BLFS icon

BioLife Solutions

80 hedge funds and large institutions have $170M invested in BioLife Solutions in 2019 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 28 increasing their positions, 21 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 4

33% more repeat investments, than reductions

Existing positions increased: 28 | Existing positions reduced: 21

13% more capital invested

Capital invested by funds: $150M → $170M (+$19.9M)

10% more funds holding

Funds holding: 7380 (+7)

2.59% more ownership

Funds ownership: 47.77%50.36% (+2.6%)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $441K

Holders
80
Holders Change
+7
Holders Change %
+9.59%
% of All Funds
1.75%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
12
Increased
28
Reduced
21
Closed
4
Calls
Puts
$441K
Net Calls
-$441K
Net Calls Change
-$441K
Name Holding Trade Value Shares
Change
Change in
Stake
Bank of New York Mellon
26
Bank of New York Mellon
New York
$1.3M +$18.3K +973 +1%
CS
27
Candriam SCA
Luxembourg
$1.26M
Wells Fargo
28
Wells Fargo
California
$1.03M -$432K -23,024 -27%
New York State Common Retirement Fund
29
New York State Common Retirement Fund
New York
$1.02M +$271K +14,441 +31%
Millennium Management
30
Millennium Management
New York
$1.01M +$528K +28,154 +87%
GIP
31
Granite Investment Partners
California
$913K
QCMC
32
Quantum Capital Management (California)
California
$785K
Bank of America
33
Bank of America
North Carolina
$534K +$464K +24,743 +335%
T. Rowe Price Associates
34
T. Rowe Price Associates
Maryland
$493K +$582 +31 +0.1%
PM
35
Penbrook Management
New York
$477K -$6.57K -350 -1%
MFIM
36
Mesirow Financial Investment Management
Illinois
$437K +$493K +26,283 New
Charles Schwab
37
Charles Schwab
California
$283K +$5.76K +307 +2%
IP
38
Isthmus Partners
Wisconsin
$276K +$312K +16,607 New
AA
39
Ancora Advisors
Ohio
$264K -$273K -14,521 -48%
Renaissance Technologies
40
Renaissance Technologies
New York
$254K -$1.98M -105,300 -87%
Morgan Stanley
41
Morgan Stanley
New York
$249K +$65.2K +3,474 +30%
Janney Montgomery Scott
42
Janney Montgomery Scott
Pennsylvania
$247K -$60.1K -3,200 -18%
RG
43
Rathbones Group
United Kingdom
$241K
CCA
44
Conestoga Capital Advisors
Pennsylvania
$239K +$10.8K +575 +4%
SKK
45
Shepherd Kaplan Krochuk
Massachusetts
$233K
CS
46
Cannell & Spears
New York
$226K
WG
47
Winton Group
United Kingdom
$225K -$161K -8,600 -39%
FPC
48
Falcon Point Capital
California
$215K +$238K +12,662 New
MFG
49
Magnus Financial Group
New York
$192K +$7.51K +400 +4%
Goldman Sachs
50
Goldman Sachs
New York
$189K +$213K +11,371 New

BLFS Hedge Fund Activity: Q3 2019 in Review

80 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in BioLife Solutions (BLFS) for Q3 2019, worth a combined $170M — up 13% from $150M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new BLFS positions and 4 closed out — a net gain of 8 holders — while 28 added to existing stakes and 21 trimmed.

The largest buyer was Park West Asset Management, adding an estimated $8.36M. The largest seller was Sandler Capital Management, cutting an estimated $4.5M.

  • 80 institutional investors held BioLife Solutions (BLFS) as of Q3 2019, up from 73 in Q2 2019.
  • Funds reported $170M of BioLife Solutions stock for Q3 2019, up 13% quarter-over-quarter.
  • 12 funds opened new BioLife Solutions positions in Q3 2019 and 4 closed out, a net change of +8 holders.
  • The largest BioLife Solutions buyer in Q3 2019 was Park West Asset Management, an estimated $8.36M added.
  • The largest BioLife Solutions seller in Q3 2019 was Sandler Capital Management, an estimated $4.5M sold.

Based on aggregated 13F filings for Q3 2019.